Apurva Popat, MD
drapurvapopat.bsky.social
Apurva Popat, MD
@drapurvapopat.bsky.social
🥼Cardiovascular Disease Fellow, USA
🩺CEO-USMLEStrike®
🌎Empowering the American Dream®
📲Download USMLEStrike® App!👨🏻‍🏫
Arterial Lines in ICU Shock Management: Evidence and Expert Insights

#criticalcare #meded #icu #medstudent #usmle
January 16, 2026 at 3:06 PM
Job's Syndrome: Clinical Features and STAT3 Mutation Explained

#usmle #neetpg #meded #fmge #medstudent
January 15, 2026 at 2:12 PM
Looks like the target trial emulation for 3SITES trial shows that ultrasound guided subclavian line has less bloodstream infection and thrombosis. The dreaded pneumothorax rates did not differ significantly when used with ultrasound.

https://link.springer.com/article/10.1186/s13054-025-05747-3
Site-specific complications of central venous catheterization under systematic ultrasound guidance: a target trial emulation revisiting the 3SITES study - Critical Care
Background Central venous catheterization is the most common invasive procedure in intensive care units but remains burdened by infectious, thrombotic, and mechanical complications. Although real-time ultrasound guidance is now widely adopted, its effect on site-specific differences in overall complication rates has not been established. The 3SITES randomized clinical trial previously demonstrated lower infection and thrombosis rates with subclavian access but higher mechanical complications. However, as only a third of its procedures were ultrasound-guided in this study, these findings may not apply to current practice. The objective of the study was to compare complication rates across these three sites under a counterfactual framework assuming universal ultrasound guidance. Methods This study was an emulated a target trial using the 3SITES dataset. Inverse probability weighting was applied to adjust for confounders of site assignment and ultrasound guidance. Weighted outcomes across catheter sites were compared under a counterfactual framework assuming universal ultrasound guidance. The...
link.springer.com
January 13, 2026 at 6:29 PM
Diagnosing Giant Cell Arteritis (GCA): Key Steps You Need to Know!

#GiantCellArteritis #MedEd #USMLE #USMLEStep1 #USMLEStep2
January 13, 2026 at 5:11 PM
🚨 Quick Immunology Check – Don’t Miss This One

Most common primary immunodeficiency?
👉 Selective IgA deficiency — simple to remember, commonly tested, often missed clinically.

#MedEd #USMLE #USMLE #USMLEStep1 #USMLEStep2
January 13, 2026 at 5:11 PM
Bruton's Disease (X-linked Agammaglobulinemia): Clinical Features and Management

#usmle #usmlestep1 #usmlestep2
January 13, 2026 at 5:04 PM
Very interesting cardiovascular disease statistics were released in JACC. Hypertension treatment and control rates have remained stagnant over the past 15 years, and related deaths have doubled. The prevalence of diabetes is higher in younger adults, with poor glycemic control.
January 13, 2026 at 12:12 AM
According to current ACC/AHA guidelines, anticoagulation for atrial fibrillation carries a Class I recommendation when the estimated annual stroke risk reaches the 2% threshold. However,
January 12, 2026 at 8:08 PM